Durand, C. M., Capoferri, A. A., Redd, A. D., Zahurak, M., Rosenbloom, D. I. S., Cash, A., Avery, R. K., Bolaños-Meade, J., Bollard, C. M., Bullen, C. K., Flexner, C., Fuchs, E. J., Gallant, J., Gladstone, D. E., Gocke, C. D., Jones, R. J., Kasamon, Y. L., Lai, J., Levis, M., Luznik, L., Marr, K. A., McHugh, H. L., Mehta Steinke, S., Pham, P., Pohlmeyer, C., Pratz, K., Shoham, S., Wagner-Johnston, N., Xu, D., Siliciano, J. D., Quinn, T. C., Siliciano, R. F., & Ambinder, R. F. (2020). allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study. Lancet, 7(9), e602–e610. http://access.bl.uk/ark:/81055/vdc_100107602398.0x000007